2 weeks on tirzepatide and no weight loss Can Help You Lose Weight? Weight loss journey with tirzepatide

Keywords: Muscle loss, GLP-1RA, Prevention, Treatment, Diabetes mellitus, Obesity Introduction A progressive decline in skeletal muscle mass and strength, or sarcopenia, is increasingly recognized as a significant comorbidity in patients with type 2 diabetes mellitus (T2D) and obesity [1, 2]

The regulator reaffirmed that these medications are strictly prescription-only, limited to authorisation by endocrinologists, internal medicine specialists, and cardiologists to prevent severe health complications arising from unsupervised use

The label expansion was supported by data from the Phase III ASC4FIRST study, in which 68% of patients treated with Scemblix achieved a major molecular response compared with 49% of those treated with standard-of-care tyrosine kinase inhibitors, including imatinib and nilotinib

doi: 10.1007/s11357-024-01359-x

Why its more effective than traditional weight loss methods Diet and exercise alone typically lead to modest resultsabout 2.4% weight reduction